No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 46, Issue 1, 2006, Pages 88-93

  Van Beek, Robert D ^a   De Muinck Keizer Schrama, Sabine M P F ^a   Hakvoort Cammel, Friederike G ^a   Van Der Sluis, Inge M ^a   Krenning, Eric P ^b   Pieters, Rob ^a   Van Den Heuvel Eibrink, Marry M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

All; Body composition; Bone mineral density; Late effects

Indexed keywords

DEXAMETHASONE; PREDNISOLONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BONE DENSITY; BONE MINERAL; BRAIN CANCER; BRAIN RADIATION; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CORTICOSTEROID THERAPY; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BODY COMPOSITION; BONE DENSITY; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DEXAMETHASONE; FEMALE; FRACTURES, BONE; GROWTH; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; NETHERLANDS; PREDNISOLONE; REGRESSION ANALYSIS; SURVIVORS;

EID: 28844498768     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20437     Document Type: Article

References (47)

1. Pui CH. Acute lymphoblastic leukemia. Pediatr Clin North Am 1997;44:831-846.
2. Veerman AJ, Hahlen K, Kamps WA, et al. High cure rate with a moderately intensive treatment regimen in non- high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996;14:911-918.
3. van der Sluis IM, de Muinck Keizer-Schrama SMPF. Osteoporosis in childhood: Bone density of children in health and disease. J Pediatr Endocrinol Metab 2001;14:817-832.
4. Boot AM, Van den Heuvel-Eibrink MM, Hählen K, et al. Bone mineral density in acute lymphoblastic leukaemia. Eur J Cancer 1999;35:1693-1697.
5. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Altered bone mineral density and body composition and fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002;141:204-210.
6. Mazur B, Mertas A, Sonta-Jakimczyk D, et al. Concentration of IL-2, IL-6, IL-8, IL-10, and TNF-alpha in children with acute lymphoblastic leukemia after cessation of chemotherapy. Hematol Oncol 2004;22:27-34.
7. Vassilopoulou-Sellin R, Ramirez I. Severe osteopenia and vertebral compression fractures after complete remission in an adolescent with acute leukemia. Am J Hematol 1992;39:142-143.
8. Warner JT, Evans WD, Webb DK, et al. Relative osteopenia after treatment for acute lymphoblastic leukemia. Pediatr Res 1999;45:544-551.
9. Tillmann V, Darlington ASE, Eiser C, et al. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. J Bone Miner Res 2002;17:1073-1080.
10. Halton JM, Atkinson SA, Fraher L, et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 1996;11:1774-1783.
11. Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood 2003;101:3809-3817.
12. van Leeuwen BL, Kamps WA, Jansen HW, et al. The effect of chemotherapy on the growing skeleton. Cancer Treat Rev 2000;26:363-376.
13. Crofton PM, Ahmed SF, Wade JC, et al. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab 1998;83:3121-3129.
14. Mandel K, Atkinson S, Barr RD, et al. Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol 2004;22:1215-1221.
15. Kaste SC, Jones-Wallace D, Rose SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: Frequency of occurrence and risk factors for their development. Leukemia 2001;15:728-734.
16. Hoorweg-Nijman JJ, Kardos G, Roos JC, et al. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia. Clin Endocrinol (Oxf) 1999;50:237-244.
17. Ito C, Evans WE, McNinch L, et al. Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. J Clin Oncol 1996;14:2370-2376.
18. Kaspers GJ, Veerman AJ, Popp-Snijders C, et al. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1996;27:114-121.
19. Arico M, Boccalatte MF, Silvestri D, et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003;88:747-753.
20. Arikoski P, Komulainen J, Voutilainen R, et al. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1998;20:234-240.
21. Brennan BM, Rahim A, Adams JA, et al. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood. Br J Cancer 1999;79:1859-1863.
22. Gilsanz V, Carlson ME, Roe TF, et al. Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. J Pediatr 1990;117:238-244.
23. Henderson RC, Madsen CD, Davis C, et al. Bone density in survivors of childhood malignancies. J Pediatr Hematol Oncol 1996;18:367-371.
24. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, et al. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 2000;35:415-420.
25. Nysom K, Holm K, Michaelsen KF, et al. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 1999;84:4591-4596.
26. Warner JT, Evans WD, Webb DK, et al. Body composition of long-term survivors of acute lymphoblastic leukaemia. Med Pediatr Oncol 2002;38:165-172.
27. Kamps WA, Bokkerink JPM, Hahlen K, et al. Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: Results of Dutch childhood leukemia study group protocol ALL-7 (1988-1991). Blood 1999;94:1226-1236.
28. Kamps WA, Bokkerink JP, Hakvoort-Cammel FG, et al. BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: Results of DCLSG protocol ALL-8 (1991-1996). Leukemia 2002;16:1099-1111.
29. van der Does-van den Berg A, van Wering ER, Suciu S, et al. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: Results of a Dutch phase III study (ALLV). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG). Am J Pediatr Hematol Oncol 1989;11:125-133.
30. van der Does-van den Berg A, de Koning J, ReerinkH, et al. [Acute juvenile lymphatic leukemia in the Netherlands: Study ALL II, 1973-5; Foundation Dutch Childhood Leukemia Study Group]. Ned Tijdschr Geneeskd 1976;120:1521-1528.
31. van der Does-van den Berg A, Veerman AJ, van Wering ER, et al. Childhood acute lymphoblastic leukemia in the Netherlands; randomized studies and nationwide treatment results from 1972-1995. Int J Pediatr Heamatol/Oncol 1996.
32. Fredriks AM, van Buuren S, Burgmeijer RJ, et al. Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 2000;47:316-323.
33. Kroger H, Vainio P, Nieminen J, et al. Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone 1995;17:157-159.
34. van der Sluis IM, de Ridder MA, Boot AM, et al. Reference data for bone density and body composition measured with dual energy x-ray absorptiometry in white children and young adults. Arch Dis Child 2002;87:341-347; discussion 347.
35. Angus RM, Sambrook PN, Pocock NA, et al. A simple method for assessing calcium intake in Caucasian women. J Am Diet Assoc 1989;89:209-214.
36. Anonymous. Dietary reference values: Calcium, vitamin D, thiamin, riboflavin, niacin, pantothenic acid, and biotin. The Hague: Health Council of the Netherlands; 2000. Report nr 2000/ 12.
37. Hokken-Koelega AC, van Doorn JW, Hahlen K, et al. Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: A comparative study. Pediatr Res 1993;33:577-582.
38. Davies HA, Didcock E, Didi M, et al. Growth, puberty and obesity after treatment for leukaemia. Acta Paediatr 1995;411):45-50; discussion 51.
39. Kirk JA, Raghupathy P, Stevens MM, et al. Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet 1987;1:190-193.
40. Cvijetic S, Korsic M. Apparent bone mineral density estimated from DXA in healthy men and women. Osteoporos Int 2004;15:295-300.
41. Benbassat CA, Eshed V, Kamjin M, et al. Are adult patients with Laron syndrome osteopenic? a comparison between dual-energy X-ray absorptiometry and volumetric bone densities. J Clin Endocrinol Metab 2003;88:4586-4589.
42. Cooper C, Cawley M, Bhalla A, et al. Childhood growth, physical activity, and peak bone mass in women. J Bone Miner Res 1995;10:940-947.
43. Nysom K, Holm K, Michaelsen KF, et al. Bone mass after treatment for acute lymphoblastic leukemia in childhood. J Clin Oncol 1998;16:3752-3760.
44. Mayer EI, Reuter M, Dopfer RE, et al. Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Horm Res 2000;53:193-199.
45. Oeffinger KC, Mertens AC, Sklar CA, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: A report from the childhood cancer survivor study. J Clin Oncol 2003;21:1359-1365.
46. van der Sluis IM, van den Heuvel MM, de Muinck Keizer-Schrama SM. Body composition in long-term survivors of childhood acute lymphoblastic leukemia (ALL). Med Pediatr Oncol 2003;40:407.
47. Visscher TL, Seidell JC. Time trends (1993-1997) and seasonal variation in body mass index and waist circumference in the Netherlands. Int J Obes Relat Metab Disord 2004;28:1309-1316.